Pablo Cure
Overview
Explore the profile of Pablo Cure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Leitao C, Bernetti K, Tharavanij T, Cure P, Ricordi C, Alejandro R
Transplantation
. 2009 Jul;
88(1):57-61.
PMID: 19584681
Background: Body fat accumulation decreases insulin sensitivity. It has being associated with earlier onset of type 1 diabetes mellitus (DM) and islet graft failure. The aim of this study was...
12.
Leitao C, Cure P, Messinger S, Pileggi A, Lenz O, Froud T, et al.
Transplantation
. 2009 Mar;
87(5):681-8.
PMID: 19295312
Background: Proteinuria development and decrease in glomerular filtration rate (GFR) have been observed after successful islet transplantation. The aim of this study was to determine clinical, laboratory, and immunosuppressant-related factors...
13.
Froud T, Baidal D, Faradji R, Cure P, Mineo D, Selvaggi G, et al.
Transplantation
. 2008 Dec;
86(12):1695-701.
PMID: 19104407
Background: Only a minority of islet transplant recipients maintain insulin independence at 5 years under the Edmonton protocol of immunosuppression. New immunosuppressive strategies are required to improve long-term outcomes. Materials...
14.
Faradji R, Tharavanij T, Messinger S, Froud T, Pileggi A, Monroy K, et al.
Transplantation
. 2008 Dec;
86(12):1658-65.
PMID: 19104401
Background: Progressive graft dysfunction (GDF) and loss of insulin independence (II) have been invariably observed in islet transplant recipients under the "Edmonton protocol." To reestablish II, we performed supplemental islet...
15.
Tharavanij T, Betancourt A, Messinger S, Cure P, Leitao C, Baidal D, et al.
Transplantation
. 2008 Nov;
86(9):1161-7.
PMID: 19005394
Background: Health related quality of life (HRQoL) is one of the most important outcomes to measure effectiveness of an intervention, especially for islet transplantation in which benefits should outweigh risks...
16.
Leitao C, Tharavanij T, Cure P, Pileggi A, Baidal D, Ricordi C, et al.
Diabetes Care
. 2008 Aug;
31(11):2113-5.
PMID: 18697903
Objective: To determine the impact of islet transplantation (ITx) on hypoglycemia awareness in patients with unstable type 1 diabetes and its relation to islet function. Research Design And Methods: A...
17.
Leitao C, Cure P, Tharavanij T, Baidal D, Alejandro R
Curr Diab Rep
. 2008 Jul;
8(4):324-31.
PMID: 18631447
Allogeneic islet transplantation is becoming a treatment option for patients with unstable type 1 diabetes mellitus (T1DM). Around 80% of the islet recipients achieve insulin independence after one or two...
18.
Capozza R, Cure-Cure C, Cointry G, Meta M, Cure P, Rittweger J, et al.
Menopause
. 2008 Jun;
15(5):905-13.
PMID: 18520697
Objective: This study evaluated dual-energy x-ray absorptiometry-assessed whole-body bone-muscle relationship (bone mineral content/lean mass [BMC/LM]) as an indicator of its nonmechanical perturbations (ie, systemic) in pre- and postmenopausal women. A...
19.
Cure P, Pileggi A, Alejandro R
N Engl J Med
. 2008 May;
358(18):1969-70.
PMID: 18450614
No abstract available.
20.
Cure P, Pileggi A, Froud T, Messinger S, Faradji R, Baidal D, et al.
Transplantation
. 2008 Mar;
85(6):801-12.
PMID: 18360260
Background: The beneficial effects of glycemic control on both survival and function of transplanted kidneys in patients with type 1 diabetes mellitus (T1DM) and end-stage renal disease (ESRD) have been...